Glucagon-like peptide-1 agonists in the treatment of type 2 diabetes
Author:
Affiliation:
1. Department of Medicine, Hillingdon Hospital, Uxbridge UB8 3NN ()
Publisher
Mark Allen Group
Subject
General Medicine
Link
http://www.magonlinelibrary.com/doi/pdf/10.12968/hmed.2013.74.4.198
Reference28 articles.
1. Effects of Intensive Glucose Lowering in Type 2 Diabetes
2. A meta-analysis of serious adverse events reported with exenatide and liraglutide: Acute pancreatitis and cancer
3. Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence
4. Effects of Exenatide on Measures of β-Cell Function After 3 Years in Metformin-Treated Patients With Type 2 Diabetes
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A review on mechanisms of action of bioactive peptides against glucose intolerance and insulin resistance;Food Science and Human Wellness;2022-11
2. A sensitive method for the quantitation of the peptide-based glucagon-like peptide-1 receptor agonist liraglutide in plasma using microfluidics chromatography tandem MS;Bioanalysis;2018-03-01
3. Pharmacokinetics and metabolism studies on the glucagon-like peptide-1 (GLP-1)-derived metabolite GLP-1(9-36)amide in male Beagle dogs;Xenobiotica;2014-03-04
4. Co-agonist of glucagon and GLP-1 reduces cholesterol and improves insulin sensitivity independent of its effect on appetite and body weight in diet-induced obese C57 mice;Canadian Journal of Physiology and Pharmacology;2013-12
5. Enteroendocrine hormone mimetics for the treatment of obesity and diabetes;Current Opinion in Pharmacology;2013-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3